Skip to main content
OpenTrials

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

5,995 public trials 1,209 recruiting studies
Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Active, Not Recruiting

Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Grade Glioma

NCT03919071

Conditions
Anaplastic Astrocytoma, Anaplastic Astrocytoma, Not Otherwise Specified, Anaplastic Ganglioglioma, +14 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Banner Children's at Desert Mesa, Arizona, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
View all 131 locations
View Trial Details
Active, Not Recruiting

A Phase 2b Clinical Study With a Combination Immunotherapy in Newly Diagnosed Patients With Glioblastoma

NCT04485949

Conditions
Astrocytoma, Glioblastoma, Glioma, +7 more
Locations
  • Mayo Clinic - Jacksonville Jacksonville, Florida, United States
  • Tufts Medical Center Boston, Massachusetts, United States
  • Henry Ford Health System Detroit, Michigan, United States
  • Dartmouth Hitchcock Medical Center Lebanon, New Hampshire, United States
View all 23 locations
View Trial Details
Active, Not Recruiting

A Study of PM8002 in Combination With Chemotherapy in Patients With NEN

NCT05879055

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +4 more
Locations
  • Chongqing University Cancer Hospital Chongqing, Chongqing Municipality, China
  • Fujian Province Cancer Hospital Fuzhou, Fujian, China
  • Harbin Medical University Cancer Hospital Harbin, Heilongjiang, China
  • The First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China
View all 13 locations
View Trial Details
Active, Not Recruiting

Study Evaluating Tarlatamab in Chinese Participants With Advanced Small Cell Lung Cancer After Two or More Prior Lines of Treatment

NCT06502977

Conditions
Extensive Stage Small Cell Lung Cancer, Neoplasms, Neoplasms by Histologic Type, +4 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • The Second Affiliated Hospital of Army Medical University, People's Liberation Army Chongqing, Chongqing Municipality, China
  • Army Special Medical Center of Peoples Liberation Army Chongqing, Chongqing Municipality, China
  • Mengchao Hepatobiliary Hospital of Fujian Medical University Fuzhou, Fujian, China
View Trial Details
Active, Not Recruiting

Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients

NCT04291105

Conditions
Carcinoma, Carcinoma, Squamous Cell, Colo-rectal Cancer, +25 more
Locations
  • Saint John's Health Center - John Wayne Cancer Institute (JWCI) Santa Monica, California, United States
  • Yale University New Haven, Connecticut, United States
  • University of Miami Miami, Florida, United States
  • Ochsner Clinic Foundation New Orleans, Louisiana, United States
View all 13 locations
View Trial Details
Active, Not Recruiting

Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma

NCT04301843

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations
  • University of Alabama/Children's of Alabama Birmingham, Alabama, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • UCSF Benioff Children's Hospital Oakland Oakland, California, United States
  • Rady Children's Hospital San Diego, California, United States
View all 31 locations
View Trial Details

Related conditions